APA (7th ed.) Citation

Horrow, J. C., Li, W., Blobner, M., Lombard, J., Speek, M., DeAngelis, M., & Herring, W. J. (2021). Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: A randomized clinical trial. BMC.

Chicago Style (17th ed.) Citation

Horrow, Jay C., Wen Li, Manfred Blobner, John Lombard, Marcel Speek, Matthew DeAngelis, and W. Joseph Herring. Actual Versus Ideal Body Weight Dosing of Sugammadex in Morbidly Obese Patients Offers Faster Reversal of Rocuronium- or Vecuronium-induced Deep or Moderate Neuromuscular Block: A Randomized Clinical Trial. BMC, 2021.

MLA (8th ed.) Citation

Horrow, Jay C., et al. Actual Versus Ideal Body Weight Dosing of Sugammadex in Morbidly Obese Patients Offers Faster Reversal of Rocuronium- or Vecuronium-induced Deep or Moderate Neuromuscular Block: A Randomized Clinical Trial. BMC, 2021.